NovoCure Ltd (NVCR)
17.73
+0.64
(+3.74%)
USD |
NASDAQ |
Nov 22, 16:00
17.72
-0.01
(-0.06%)
After-Hours: 20:00
NovoCure Debt to Equity Ratio: 1.814 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.814 |
| June 30, 2024 | 1.806 |
| March 31, 2024 | 1.585 |
| December 31, 2023 | 1.569 |
| September 30, 2023 | 1.443 |
| June 30, 2023 | 1.364 |
| March 31, 2023 | 1.310 |
| December 31, 2022 | 1.282 |
| September 30, 2022 | 1.268 |
| June 30, 2022 | 1.277 |
| March 31, 2022 | 1.292 |
| December 31, 2021 | 1.370 |
| September 30, 2021 | 1.359 |
| June 30, 2021 | 1.411 |
| March 31, 2021 | 1.504 |
| December 31, 2020 | 0.9022 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.5582 |
| March 31, 2020 | 0.6178 |
| December 31, 2019 | 0.6861 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.7847 |
| June 30, 2019 | 0.9398 |
| March 31, 2019 | 1.181 |
| December 31, 2018 | 1.330 |
| September 30, 2018 | 1.298 |
| June 30, 2018 | 1.331 |
| March 31, 2018 | 1.406 |
| December 31, 2017 | 0.8626 |
| September 30, 2017 | 0.8317 |
| June 30, 2017 | 0.8232 |
| March 31, 2017 | 0.7486 |
| December 31, 2016 | 0.6798 |
| September 30, 2016 | 0.6065 |
| June 30, 2016 | 0.1248 |
| March 31, 2016 | 0.1052 |
| December 31, 2015 | 0.0921 |
| September 30, 2015 | 0.2026 |
| June 30, 2015 | 0.17 |
| March 31, 2015 | |
| December 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2020
1.814
Maximum
Sep 2024
1.221
Average
1.335
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.3764 |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 0.0157 |
| Xtant Medical Holdings Inc | 0.7605 |
| Catheter Precision Inc | 0.1364 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.222B |
| Total Liabilities (Quarterly) | 861.20M |
| Shareholders Equity (Quarterly) | 360.78M |
| Current Ratio | 1.490 |
| Net Debt Paydown Yield | -1.03% |